Factors influencing the formulation of semisolid preparations with special reference to corticosteroid products.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D003879:Dermatologic Agents; D004304:Dosage Forms; D004341:Drug Evaluation; D004355:Drug Stability; D004655:Emulsions; D005938:Glucocorticoids; D006801:Humans; D007664:Ketosteroids / Q000008:administration & dosage; D009824:Ointments; D010316:Particle Size; D010592:Pharmaceutic Aids; D014677:Pharmaceutical Vehicles; D011244:Pregnadienediols / Q000008:administration & dosage*; D012869:Skin Absorption; D012995:Solubility; D012996:Solutions; D013258:Steroids, Chlorinated / Q000008:administration & dosage; D013259:Steroids, Fluorinated / Q000008:administration & dosage; D013501:Surface-Active Agents; D014783:Viscosity
D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D004304:Dosage Forms; D004655:Emulsions; D005938:Glucocorticoids; D007664:Ketosteroids; D009824:Ointments; D010592:Pharmaceutic Aids; D014677:Pharmaceutical Vehicles; D011244:Pregnadienediols; D012996:Solutions; D013258:Steroids, Chlorinated; D013259:Steroids, Fluorinated; D013501:Surface-Active Agents